Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Landmark Study For GSK's Cervical Cancer Vaccine Published In The Lancet
The final analysis of the largest efficacy trial of a cervical cancer vaccine is published today in The Lancet. The study, involving 18,644 women, confirmed GlaxoSmithKline"s Cervarix(R) is highly effective at protecting against the two most common cervical cancer-causing human papillomavirus (HPV) types, 16 and 18. The study also showed that the vaccine provides cross-protection against HPV types 31, 33 and 45, the three most common cancer-causing virus types beyond 16 and 18.
generic viagra online
"Thousands Have Lived Without Love, Not One Without Water"
Water for Work and Home, an innovative wellbeing organisation, is providing the essential water to keep the "living monuments" hydrated whilst on the Fourth Plinth.
News of the day
Nç©ovacs To Expand Clinical Testing Of Its TNF-alpha Kinoid Lead Product Candidate Following Positive Preliminary Findings From A Phase I/II Study
Neovacs, a biotechnology company developing proprietary immunotherapeutics for autoimmune and chronic diseases, announced that subject to regulatory consent, it plans to initiate a Phase II study of its TNF-alpha Kinoid later this year in rheumatoid arthritis patients who have failed treatment with at least one TNF-alpha inhibitor. The decision to proceed with the trial was based on an initial review of encouraging data from the company"s Phase I/II study in Crohn"s disease.
Diagnostics

Zuma, Branson Collaborate To Establish Disease Control Center In South Africa

South African President Jacob Zuma and Virgin Group founder and chair Richard Branson "intend [on] establishing a disease control centre in South Africa as soon as next year," SAPA/The Times reports. "Branson said the initiative, expected to be launched by March, would be 50 percent private and 50 percent government funded," the news service writes (7/22). Branson and Zuma "said in a statement Wednesday they had discussed jointly establishing the equivalent of the U.S. Centers for Disease Control and Prevention. More talks will be held to refine the idea," the AP/Boston Herald writes (7/22). In addition to providing a central location for research and information on epidemic diseases, the center aims "to enhance the government"s ability to respond more effectively to health emergencies," the Financial Times writes. The newspaper reports that the initial budget for the center is set at "up to $20 million." "[This] is a critical initiative to help stop needless suffering from diseases such as tuberculosis, AIDS and other health conditions that have needlessly killed large numbers of people and hampered the growth of this incredible country," said Branson, who is partly funding the center. Zuma "said the new centre would be "an innovative and needed re to help strengthen our health system and health information"" (Lapper, 7/22). SAPA/The Times writes, "Zuma echoed Branson"s ideals that a centre of this nature was a good start, and that its benefits would be felt by sub-Saharan countries" (7/22). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009